25 related articles for article (PubMed ID: 31126198)
1. miR-101-3p Serves as a Tumor Suppressor for Renal Cell Carcinoma and Inhibits Its Invasion and Metastasis by Targeting EZH2.
Dong Y; Gao Y; Xie T; Liu H; Zhan X; Xu Y
Biomed Res Int; 2021; 2021():9950749. PubMed ID: 34307682
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of breast cancer metastasis by co-transfection of miR-31/193b-mimics.
Hashemi ZS; Moghadam MF; Farokhimanesh S; Rajabibazl M; Sadroddiny E
Iran J Basic Med Sci; 2018 Apr; 21(4):427-433. PubMed ID: 29796229
[TBL] [Abstract][Full Text] [Related]
3. miR‑193b exhibits mutual interaction with MYC, and suppresses growth and metastasis of osteosarcoma.
Gao J; Ma S; Yang F; Chen X; Wang W; Zhang J; Li Y; Wang T; Shan L
Oncol Rep; 2020 Jul; 44(1):139-155. PubMed ID: 32377743
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA Associated with the Invasive Phenotype in Clear Cell Renal Cell Carcinoma: Let-7c-5p Inhibits Proliferation, Migration, and Invasion by Targeting Insulin-like Growth Factor 1 Receptor.
Kalantzakos TJ; Sebel LE; Trussler J; Sullivan TB; Burks EJ; Sarita-Reyes CD; Canes D; Moinzadeh A; Rieger-Christ KM
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289686
[TBL] [Abstract][Full Text] [Related]
5. Dichotomous role of miR193b-3p in diabetic foot ulcers maintains inhibition of healing and suppression of tumor formation.
Marjanovic J; Ramirez HA; Jozic I; Stone RC; Wikramanayake TC; Head CR; Abdo Abujamra B; Ojeh N; Kirsner RS; Lev-Tov H; Pastar I; Tomic-Canic M
Sci Transl Med; 2022 May; 14(644):eabg8397. PubMed ID: 35544594
[TBL] [Abstract][Full Text] [Related]
6. Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical
Weidle UH; Nopora A
Cancer Genomics Proteomics; 2021; 18(3 Suppl):349-368. PubMed ID: 33994361
[TBL] [Abstract][Full Text] [Related]
7. CircATP5SL promotes infantile haemangiomas progression via IGF1R regulation by targeting miR-873-5p.
Wei Z; Yuan X; Ding Q; Xu Y; Hong L; Wang J
Am J Transl Res; 2021; 13(3):1322-1336. PubMed ID: 33841659
[TBL] [Abstract][Full Text] [Related]
8. The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia.
Ghafouri-Fard S; Abak A; Mohaqiq M; Shoorei H; Taheri M
Front Cell Dev Biol; 2021; 9():634512. PubMed ID: 33768092
[TBL] [Abstract][Full Text] [Related]
9. Long non‑coding RNA BANCR mediates esophageal squamous cell carcinoma progression by regulating the IGF1R/Raf/MEK/ERK pathway via miR‑338‑3p.
Song W; Wang K; Yang X; Dai W; Fan Z
Int J Mol Med; 2020 Oct; 46(4):1377-1388. PubMed ID: 32945416
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-1 signaling in renal cell carcinoma.
Tracz AF; Szczylik C; Porta C; Czarnecka AM
BMC Cancer; 2016 Jul; 16():453. PubMed ID: 27405474
[TBL] [Abstract][Full Text] [Related]
12. MiR-193b inhibits the growth and metastasis of renal cell carcinoma by targeting IGF1R.
Chen J; Deng T; Li X; Cai W
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):2058-2064. PubMed ID: 31126198
[No Abstract] [Full Text] [Related]
13. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
Wang X; Li H; Cui L; Feng J; Fan Q
Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875
[TBL] [Abstract][Full Text] [Related]
14. miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.
Du Y; Li Y; Lv H; Zhou S; Sun Z; Wang M
Int J Clin Exp Pathol; 2015; 8(10):12252-9. PubMed ID: 26722410
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
